StonvexLoading…
StonvexStonvexStonvexCore line items from CRTO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $424.64M | $1.94B | $934.11M | $451.43M |
Operating Income | $10.40M | $202.76M | $78.62M | $48.17M |
Net Income | $7.82M | $144.60M | $59.18M | $37.93M |
EPS (Diluted) | $0.15 | $2.64 | $1.05 | $0.66 |
Total Assets | $2.07B | $2.20B | $2.11B | $2.13B |
Total Liabilities | $902.62M | $1.02B | $986.61M | $1.03B |
Cash & Equivalents | $319.98M | $342.04M | $205.70M | $285.85M |
Free Cash Flow OCF − CapEx | $15.36M | $208.50M | $8.60M | $45.25M |
Shares Outstanding | 50.10M | 51.15M | 57.85M | 57.85M |